ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
4,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
6,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
6,5,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
6,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
7,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
7,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
7,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
9,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
9,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
10,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
10,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
10,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
11,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
11,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
11,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
11,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
12,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
12,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
12,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
14,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,2,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
14,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
14,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
15,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
15,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
16,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
17,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
17,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
18,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
18,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
19,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
20,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
20,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
20,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
21,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
21,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
21,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
22,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
22,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
22,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
22,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
23,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
23,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
24,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
25,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
26,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
26,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
27,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
28,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
29,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
30,1,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
30,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
30,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
30,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
30,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
31,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
31,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
31,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
31,6,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
31,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
31,8,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
31,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
31,10,Toxic shock syndrome,Infections NEC,Infections - pathogen unspecified,Infec,N
31,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
32,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
33,1,Rash follicular,Pustular conditions,Epidermal and dermal conditions,Skin,N
34,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
34,2,Headache,Headaches NEC,Headaches,Nerv,N
34,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
34,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
34,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
35,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
35,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
35,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
36,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
36,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
37,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
38,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
38,2,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
38,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
38,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
39,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
40,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
41,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
41,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
41,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
41,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
41,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
41,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
41,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
41,8,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
41,9,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
42,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
42,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
43,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
43,2,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
44,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
44,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
44,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
44,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
44,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
44,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
44,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
44,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
45,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
45,2,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
45,3,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
45,4,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
46,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
46,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
46,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
46,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
46,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
47,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
47,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
47,3,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
48,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,Y
49,1,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
49,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
49,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
49,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
50,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
50,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
50,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
50,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
51,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
52,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
52,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
52,4,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
52,5,Lymph node abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
52,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
52,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,8,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
53,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
54,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
54,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
54,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
54,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
54,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
54,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
55,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
55,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
55,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
55,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
55,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
55,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
55,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
56,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
56,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
56,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
57,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
57,2,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
58,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
59,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
59,2,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
60,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
60,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
61,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
61,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
61,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
61,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
62,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
63,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
63,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
63,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
64,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
64,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
64,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
64,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
64,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
65,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
65,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
65,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
65,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
65,5,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
65,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
66,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
66,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
67,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,Y
67,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
67,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
68,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
69,1,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
70,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
71,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
71,2,Nephroblastoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
72,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
72,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
73,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
74,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
75,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
75,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
76,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
77,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
78,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
79,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
79,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
79,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
79,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
79,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
79,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
79,7,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
80,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
80,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
81,1,Human chorionic gonadotropin increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
81,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
81,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
81,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
81,5,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
82,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
83,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
84,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
84,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
85,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
86,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
87,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
87,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
87,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
88,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
88,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
89,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
89,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
90,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
90,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
91,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
92,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
92,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
92,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
93,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
93,2,Abnormal clotting factor,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
93,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
93,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
93,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
93,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
93,8,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
94,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
95,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
95,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
95,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
96,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
96,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
97,1,Candida test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
97,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
97,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
97,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
97,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
97,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
97,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
97,8,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
97,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
98,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
98,2,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
98,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
99,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
99,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
99,3,Headache,Headaches NEC,Headaches,Nerv,N
99,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
99,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
99,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
100,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
100,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
101,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
101,2,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
101,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
101,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
101,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
101,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
101,7,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
101,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
101,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,10,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
101,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
102,1,Ewing's sarcoma recurrent,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
103,1,Metaplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
103,2,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
104,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
104,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
105,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
105,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
105,3,Haemofiltration,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
105,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
105,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
105,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
105,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
105,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
105,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
105,10,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
106,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
106,2,Desmoplastic small round cell tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
106,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
106,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
106,7,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
106,8,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
106,9,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
106,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
106,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
106,12,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
108,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
108,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
108,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
108,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
108,5,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
108,6,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
108,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
109,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
109,2,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
110,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
110,2,Umbilical hernia,Umbilical hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
111,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
111,2,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
112,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
112,2,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
113,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
114,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
115,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
116,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
117,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
117,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
117,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
118,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
118,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
119,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
119,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
119,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
119,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
120,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
121,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
121,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
121,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
122,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
122,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
122,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
123,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
124,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
124,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
124,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
124,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
124,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
125,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
125,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
126,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
126,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,6,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
126,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,1,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
127,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
128,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
129,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
129,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
129,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
129,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
129,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
129,6,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
129,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
130,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
131,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
131,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
132,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
132,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
132,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
132,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
132,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
132,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
132,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
132,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
133,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
134,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
134,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
135,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
135,2,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,3,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
135,4,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
135,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
135,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
135,7,Tumour embolism,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
136,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
136,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
136,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
136,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
137,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
137,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
138,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
138,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
138,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
139,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
140,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
140,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
141,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
142,1,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
143,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
143,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
143,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
143,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
144,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
144,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
145,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
145,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
146,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
147,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
147,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
147,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
147,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
147,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
147,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
147,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
147,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
148,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
149,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
149,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
150,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
150,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
150,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
151,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
151,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
